Research

Prevention of hepatocellular carcinoma with antiviral therapy

AM Di Bisceglie

Abstract


Chronic viral hepatitis types B and C may eventually lead to the development of hepatocellular carcinoma. Although hepatitis B is readily preventable by vaccination, there is growing evidence that antiviral therapy directed against hepatitis B may reduce the risk of liver cancer among those already infected. There is no vaccine against hepatitis C, but the evidence is now strong that antiviral therapy with sustained virological response (viral cure) reduces, but does not eliminate, the risk of hepatocellular carcinoma.


Author's affiliations

AM Di Bisceglie, Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA

Full Text

PDF (112KB)

Cite this article

South African Medical Journal 2018;108(8b):47-50. DOI:10.7196/SAMJ.2018.v108i8b.13501

Article History

Date submitted: 2018-08-08
Date published: 2018-08-08

Article Views

Abstract views: 134
Full text views: 133

Comments on this article

*Read our policy for posting comments here